MedPath

A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver Transplantation

Recruiting
Conditions
Portal Vein Thrombosis
Registration Number
NCT06513780
Lead Sponsor
Ru-zhou Cai
Brief Summary

The goal of this observational study is to investigate the correlation between portal vein thrombosis (PVT) and the prognosis of liver transplantation. The main questions it aims to address are:

What is the prevalence of PVT? What are the risk factors associated with PVT? What is the prognostic impact of preoperative PVT on liver transplantation?

Participants are divided into two groups: the PVT group and the non-PVT group. The investigators will comparatively analyze the data of both groups, estimate the prevalence and risk factors of PVT, construct a predictive model for PVT that is applicable in clinical settings, and clarify the prognostic effects of PVT.

Detailed Description

The investigators aim to investigate the prevalence and risk factors of PVT, to develop a novel grading or rating system for PVT, and to explore the prognostic impact of preoperative PVT in liver transplantation.

The investigators will:

Recruit patients according to the inclusion/exclusion criteria and obtain signed informed consents. They will collect demographic and laboratory characteristics and classify patients into the PVT group and the non-PVT group based on preoperative ultrasound and/or computed tomography.

Collect patients' perioperative medical imaging, surgical procedures, pathology reports, postoperative treatments, follow-up data, and clinical endpoints.

Comparatively analyze the data of the PVT and non-PVT groups, estimate the prevalence and risk factors of PVT, construct a predictive model for PVT that is applicable in clinical settings, clarify the prognostic effects of PVT, and propose a grading/rating system for PVT.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
700
Inclusion Criteria
  1. Liver transplantation recipients
  2. Aged 18 years or older.
Exclusion Criteria
  1. Retransplantation
  2. Multi-organ transplantation
  3. Portal vein tumor thrombus

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postoperative portal vein stenosis10 years

Number of participants with portal vein stenosis after liver transplant

Death10 years

Rate of death from various causes after liver transplant

Postoperative portal vein thrombosis10 years

Number of participants with portal vein thrombosis after liver transplant

Secondary Outcome Measures
NameTimeMethod
Postoperative complications1 year

Rate of re-surgery, interventional operation, endoscopy, dialysis, etc.

Trial Locations

Locations (1)

Beijing Friendship Hospital, Capital Medical University

🇨🇳

Beijing, China

Beijing Friendship Hospital, Capital Medical University
🇨🇳Beijing, China
Ruzhou Cai
Contact
18722563616
18722563616@126.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.